| Product NDC: | 0019-0862 |
| Proprietary Name: | Cysto-Conray |
| Non Proprietary Name: | Iothalamate meglumine |
| Active Ingredient(s): | 172 mg/mL & nbsp; Iothalamate meglumine |
| Administration Route(s): | URETERAL |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0019-0862 |
| Labeler Name: | Mallinckrodt Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017057 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101008 |
| Package NDC: | 0019-0862-07 |
| Package Description: | 12 BOTTLE, GLASS in 1 BOX (0019-0862-07) > 250 mL in 1 BOTTLE, GLASS |
| NDC Code | 0019-0862-07 |
| Proprietary Name | Cysto-Conray |
| Package Description | 12 BOTTLE, GLASS in 1 BOX (0019-0862-07) > 250 mL in 1 BOTTLE, GLASS |
| Product NDC | 0019-0862 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Iothalamate meglumine |
| Dosage Form Name | INJECTION |
| Route Name | URETERAL |
| Start Marketing Date | 20101008 |
| Marketing Category Name | NDA |
| Labeler Name | Mallinckrodt Inc. |
| Substance Name | IOTHALAMATE MEGLUMINE |
| Strength Number | 172 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |